SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

R1 RCM Inc. – ‘10-Q’ for 9/30/18 – ‘EX-10.1’

On:  Wednesday, 11/7/18, at 9:02am ET   ·   For:  9/30/18   ·   Accession #:  1628280-18-13834   ·   File #:  1-34746

Previous ‘10-Q’:  ‘10-Q’ on 8/9/18 for 6/30/18   ·   Next:  ‘10-Q’ on 5/9/19 for 3/31/19   ·   Latest:  ‘10-Q’ on 5/9/22 for 3/31/22   ·   5 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/07/18  R1 RCM Inc.                       10-Q        9/30/18  107:8.5M                                   Workiva Inc Wde… FA01/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    651K 
 2: EX-10.1     Material Contract                                   HTML     65K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     34K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     30K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     31K 
13: R1          Document and Entity Information                     HTML     52K 
14: R2          Consolidated Balance Sheets                         HTML    134K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     60K 
16: R4          Consolidated Statements of Operations and           HTML    111K 
                Comprehensive Income (Loss)                                      
17: R5          Consolidated Statements of Operations and           HTML     32K 
                Comprehensive Income (Loss) (Parenthetical)                      
18: R6          Consolidated Statements of Stockholders' Equity     HTML     82K 
                (Deficit) (Unaudited)                                            
19: R7          Consolidated Statements of Stockholders' Equity     HTML     31K 
                (Deficit) (Unaudited) (Parenthetical)                            
20: R8          Consolidated Statements of Cash Flows               HTML    134K 
21: R9          Business Description and Basis of Presentation      HTML     53K 
22: R10         Recent Accounting Pronouncements                    HTML     39K 
23: R11         Fair Value of Financial Instruments                 HTML     38K 
24: R12         Acquisition                                         HTML     74K 
25: R13         Accounts Receivable and Allowance for Doubtful      HTML     49K 
                Accounts                                                         
26: R14         Property, Equipment and Software                    HTML     62K 
27: R15         Intangible Assets                                   HTML     68K 
28: R16         Goodwill                                            HTML     37K 
29: R17         Revenue Recognition                                 HTML    126K 
30: R18         Customer Liabilities                                HTML     47K 
31: R19         Debt                                                HTML     72K 
32: R20         Stockholders' Equity (Deficit)                      HTML     44K 
33: R21         Share-Based Compensation                            HTML    122K 
34: R22         Other                                               HTML     62K 
35: R23         Income Taxes                                        HTML     44K 
36: R24         8.00% Series A Convertible Preferred Stock          HTML     49K 
37: R25         Earnings (Loss) Per Share                           HTML     87K 
38: R26         Commitments and Contingencies                       HTML     35K 
39: R27         Related Party Transactions                          HTML     60K 
40: R28         Deferred Contract Costs                             HTML    126K 
41: R29         Segments and Customer Concentrations                HTML     37K 
42: R30         Derivative Financial Instruments                    HTML     76K 
43: R31         Recent Accounting Pronouncements (Policies)         HTML     77K 
44: R32         Acquisition (Tables)                                HTML     63K 
45: R33         Accounts Receivable and Allowance for Doubtful      HTML     47K 
                Accounts (Tables)                                                
46: R34         Property, Equipment, and Software (Tables)          HTML     63K 
47: R35         Intangible Assets (Tables)                          HTML     71K 
48: R36         Goodwill (Tables)                                   HTML     36K 
49: R37         Revenue Recognition (Tables)                        HTML     90K 
50: R38         Customer Liabilities (Tables)                       HTML     46K 
51: R39         Debt (Tables)                                       HTML     44K 
52: R40         Share-Based Compensation (Tables)                   HTML    119K 
53: R41         Other (Tables)                                      HTML     62K 
54: R42         8.00% Series A Convertible Preferred Stock          HTML     41K 
                (Tables)                                                         
55: R43         Earnings (Loss) Per Share (Tables)                  HTML     83K 
56: R44         Related Party Transactions (Tables)                 HTML     56K 
57: R45         Deferred Contract Costs (Tables)                    HTML     39K 
58: R46         Derivative Financial Instruments (Tables)           HTML     78K 
59: R47         Business Description and Basis of Presentation -    HTML     59K 
                Narrative (Details)                                              
60: R48         Recent Accounting Pronouncements - Narrative        HTML     32K 
                (Details)                                                        
61: R49         Fair Value of Financial Instruments - Narrative     HTML     34K 
                (Details)                                                        
62: R50         Acquisition - Narrative (Details)                   HTML     72K 
63: R51         Acquisition - Fair Value of Assets Acquired and     HTML     70K 
                Liabilities Assumed (Details)                                    
64: R52         Acquisition - Pro Forma Results (Details)           HTML     36K 
65: R53         Accounts Receivable and Allowance for Doubtful      HTML     40K 
                Accounts - Schedule of Allowance for Doubtful                    
                Accounts (Details)                                               
66: R54         Property, Equipment, and Software - Schedule of     HTML     50K 
                Property, Equipment and Software (Details)                       
67: R55         Property, Equipment and Software - Narrative        HTML     37K 
                (Details)                                                        
68: R56         Property, Equipment, and Software - Allocation of   HTML     36K 
                Depreciation and Amortization Expense between Cost               
                of Services and Selling, General and                             
                Administrative Expenses (Details)                                
69: R57         Intangible Assets - Components of Intangible        HTML     52K 
                Assets (Details)                                                 
70: R58         Intangible Assets - Narrative (Details)             HTML     32K 
71: R59         Intangible Assets - Future Amortization (Details)   HTML     45K 
72: R60         Goodwill - Carrying Amount of Goodwill (Details)    HTML     34K 
73: R61         Revenue Recognition - Narrative (Details)           HTML     54K 
74: R62         Revenue Recognition - Schedule of Disaggregated     HTML     40K 
                Revenue by Source (Details)                                      
75: R63         Revenue Recognition - Schedule of Contract          HTML     37K 
                Balances (Details)                                               
76: R64         Revenue Recognition - Schedule of Changes in        HTML     39K 
                Contract Assets and Contract Liabilities (Details)               
77: R65         Revenue Recognition - Transaction Price Allocated   HTML     71K 
                to the Remaining Performance Obligation (Details)                
78: R66         Customer Liabilities - Schedule of Customer         HTML     44K 
                Liabilities (Details)                                            
79: R67         Debt - Carrying Amounts of Debt (Details)           HTML     52K 
80: R68         Debt - Narrative (Details)                          HTML    122K 
81: R69         Stockholders' Equity (Deficit) - Narrative          HTML    117K 
                (Details)                                                        
82: R70         Share-Based Compensation - Narrative (Details)      HTML     86K 
83: R71         Share-Based Compensation - Compensation Expense     HTML     43K 
                Allocation (Details)                                             
84: R72         Share-Based Compensation - Assumptions (Details)    HTML     48K 
85: R73         Share-Based Compensation - Stock Option Activity    HTML     58K 
                (Details)                                                        
86: R74         Share-Based Compensation - Restricted Stock Award   HTML     55K 
                Activity (Details)                                               
87: R75         Share-Based Compensation - Restricted Stock Unit    HTML     61K 
                Activity (Details)                                               
88: R76         Other - Narrative (Details)                         HTML     31K 
89: R77         Other - Other Costs (Details)                       HTML     51K 
90: R78         Income Taxes - Narrative (Details)                  HTML     56K 
91: R79         8.00% Series A Convertible Preferred Stock -        HTML     81K 
                Narrative (Details)                                              
92: R80         8.00% Series A Convertible Preferred Stock -        HTML     42K 
                Schedule of Preferred Stock Activity (Details)                   
93: R81         Earnings (Loss) Per Share - Computation of Basic    HTML     68K 
                Diluted Earnings Per Share (Details)                             
94: R82         Earnings (Loss) Per Share - Narrative (Details)     HTML     34K 
95: R83         Related Party Transactions - Narrative (Details)    HTML     43K 
96: R84         Related Party Transactions - Net Services Revenue   HTML     32K 
                (Details)                                                        
97: R85         Related Party Transactions - Summary Amounts        HTML     51K 
                Included in Balance Sheet (Details)                              
98: R86         Deferred Contract Costs - Summary of Deferred       HTML     36K 
                Contract Costs (Details)                                         
99: R87         Deferred Contract Costs - Narrative (Details)       HTML     34K 
100: R88         Segments and Customer Concentrations - Narrative    HTML     45K  
                (Details)                                                        
101: R89         Derivative Financial Instruments - Narrative        HTML     54K  
                (Details)                                                        
102: R90         Derivative Financial Instruments - Effect of        HTML     41K  
                Derivative on Statement of Operations (Details)                  
103: R91         Derivative Financial Instruments - Fair Value of    HTML     44K  
                Derivatives Included in Balance Sheets (Details)                 
104: R92         Derivative Financial Instruments - Offsetting of    HTML     43K  
                Derivatives (Details)                                            
106: XML         IDEA XML File -- Filing Summary                      XML    195K  
105: EXCEL       IDEA Workbook of Financial Reports                  XLSX    112K  
 7: EX-101.INS  XBRL Instance -- ah-20180930                         XML   2.27M 
 9: EX-101.CAL  XBRL Calculations -- ah-20180930_cal                 XML    246K 
10: EX-101.DEF  XBRL Definitions -- ah-20180930_def                  XML    895K 
11: EX-101.LAB  XBRL Labels -- ah-20180930_lab                       XML   1.88M 
12: EX-101.PRE  XBRL Presentations -- ah-20180930_pre                XML   1.24M 
 8: EX-101.SCH  XBRL Schema -- ah-20180930                           XSD    208K 
107: ZIP         XBRL Zipped Folder -- 0001628280-18-013834-xbrl      Zip    266K

‘EX-10.1’   —   Material Contract

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

 <!   C:   C: 
  Exhibit  


Exhibit 10.1

AMENDMENT NO. 3 TO
AMENDED AND RESTATED MASTER PROFESSIONAL SERVICES AGREEMENT
BY AND BETWEEN
ASCENSION HEALTH AND R1 RCM INC.

This Amendment No. 3 to the Master Professional Services Agreement (this “Amendment”) by and between Ascension Health (“Ascension Health”) and R1 RCM Inc. (formerly known as Accretive Health, Inc.) (“R1”) is entered into effective this 5th day of July, 2018 (the “Amendment Effective Date”). Ascension Health and R1 are sometimes referred to in herein as a “Party” or collectively as the “Parties”. All capitalized terms used and not otherwise defined herein shall have the meaning ascribed to them in the MPSA (as defined below).
WHEREAS, Ascension Health and R1 entered into that certain Amended and Restated Master Professional Services Agreement dated February 16, 2016, as amended (the “MPSA”); and
WHEREAS, Ascension Health and Supplier desire to revise the calculation of the Base Fee set out in the MPSA to create a single Base Fee which will apply to all Steady State Eligible Recipients (as defined below), which will be calculated using the Base Fee components set forth in the Existing Supplements, the Supplements for each of the Additional Book Eligible Recipients that are Steady State Eligible Recipients and Supplement A-01 to the MPSA (“NRIT Supplement”);
NOW, THEREFORE, in consideration of the mutual promises and covenants contained in this Amendment, and of other good and valid consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:
I.
Base Fee for Dependent Services. Effective as of July 1, 2018, Exhibit 4-A to the MPSA is hereby amended as follows:

a.
Sections 1.1 and 1.2 of Exhibit 4-A are hereby deleted in their entirety and replaced with the following:

“For Supplier’s provision of Dependent Services to the Eligible Recipients, Ascension Health will pay to Supplier a base fee (the “Base Fee”), which Base Fee shall be comprised of:
1.1
a single [**] fee with respect to the Steady State Eligible Recipients, which will be calculated in the aggregate (to be invoiced in accordance with Exhibit 4-D) equal to the product of:

(i)
the sum of the [**]-Month Rolling Average Cash Collections with respect to such month for all of the Steady State Eligible Recipients in the aggregate,

multiplied by

(ii)
the result of:

[**] Indicates that text has been omitted which is the subject of a confidential treatment request. The text has been separately filed with the Securities and Exchange Commission.


a.
the Blended Ascension Cost to Collect Factor (as defined in Section 1.3(vii))

minus

b.
[**];
 
(the portion of the Base Fee described in this Section 1.1, the “Steady State Base Fee”)

and

1.2
with respect to each Additional Book Eligible Recipient that is not a Steady State Eligible Recipient that has commenced receiving Dependent Services from Supplier, a [**] fee (to be invoiced in accordance with Exhibit 4-D) equal to the product of:

(i)
the [**]-Month Rolling Average Cash Collections with respect to such month for such Additional Book Eligible Recipient,

multiplied by

(ii)
the result of:

a.
the Additional Book Cost to Collect Factor (as defined in Section 3.2) applicable to such Additional Book Eligible Recipient,

minus

b.
[**].

It is the intent of the Parties to commence Dependent Services on the first day of any month; however, in the event any Dependent Services do not start on the first of a month, the Parties shall account for any proration in the Base Fees in accordance with Section 11.1(c) of the MPSA.”
b.
Section 1.3(ii) of Exhibit 4-A is hereby deleted in its entirety and replaced with the following:

“(ii)    “[**]-Month Rolling Average Cash Collections” means, with respect to an Eligible Recipient, the average for [**] Cash Collections received by such Eligible Recipient based on the Cash Collections during the [**]-month period that ends [**] prior to the [**] that includes the [**] for which the Base Fee is payable.
For example, to calculate the Base Fee for [**], the [**]-Month Rolling Average Cash Collections attributable to an Eligible Recipient would equal the [**] Cash Collections received by such Eligible Recipient in [**].”

2
[**] Indicates that text has been omitted which is the subject of a confidential treatment request. The text has been separately filed with the Securities and Exchange Commission.

c.
The following definitions are hereby added to Section 1.3 of Exhibit 4-A:

“(vi)    “Ascension Health Fiscal Year” means the twelve-month period ending on June 30th of any calendar year. For example, Ascension Health Fiscal Year 2019 is the period from July 1, 2018 through June 30, 2019.
(vii)    “Steady State Eligible Recipient” means, in any given Ascension Health Fiscal Year, (a) Columbia St. Mary’s, Ministry (MHS) and Wheaton Franciscan Healthcare (collectively, “Ascension Wisconsin”), (b) each of the Current Book Eligible Recipients, and (c) each of the Additional Book Eligible Recipients and New ABMs for which the Tranche End Date has occurred prior to the first day of such Ascension Health Fiscal Year. For clarity, Ascension Wisconsin will be treated as a single Eligible Recipient for purposes of calculating the Base Fee.
(viii)    “Blended Ascension Cost to Collect Factor” means, for a particular Ascension Health Fiscal Year, the result of:
(x) the sum of the results, for each of the Steady State Eligible Recipients (in the aggregate), of:
the product of:
(i) Cash Collections received by such Steady State Eligible Recipient during the Blended Ascension Cost to Collect Factor Cash Collection Period,
multiplied by
(ii) the sum of: (A) the Current Book Cost to Collect Factor, the Additional Book Cost to Collect Factor, or the Ascension Wisconsin Cost to Collect Factor, as applicable for such Steady State Eligible Recipient, plus (B) the HIM Cash Collection Factor (as defined in the NRIT Supplement), if applicable, plus (C) the NRIT Cash Collection Factor (as defined in the NRIT Supplement), if applicable,
(the intermediate result described in this subpart “x”, the “Composite Base Fee”)
divided by
(y) the sum of Cash Collections received for all such Steady State Eligible Recipients (in the aggregate) during the Blended Ascension Cost to Collect Factor Cash Collection Period.
(ix)    “Blended Ascension Cost to Collect Factor Cash Collection Period” means, for purposes of calculating the Blended Ascension Cost to Collect Factor for a particular Ascension Health Fiscal Year [**].”


3
[**] Indicates that text has been omitted which is the subject of a confidential treatment request. The text has been separately filed with the Securities and Exchange Commission.


d.
The first sentence of the third paragraph of Section 2.1 of Exhibit 4-A is hereby deleted in its entirety and replaced with the following:

“For the avoidance of doubt, the Current Book Cost to Collect Factor for each Current Book Eligible Recipient that will be used to determine the Blended Ascension Cost to Collect Factor for the Base Fee calculation in Section 1.1 as of July 1, 2018 shall equal the sum of:
(i)
the applicable Initial Current Book Cost to Collect Factor, and
(ii)
the aggregated value of all CB Adjustments (as defined in Section 2.2) for the applicable Current Book Eligible Recipient, as approved by the Cost Board in connection with the applicable CB Re-Assessment.

e.
The first sentence of the third paragraph of Section 3.2 of Exhibit 4-A is hereby deleted in its entirety and replaced with the following:

“The Additional Book Cost to Collect Factor for each Additional Book Eligible Recipient that will be (i) for Additional Book Eligible Recipients that are Steady State Eligible Recipients, used to determine the Blended Ascension Cost to Collect Factor for the Base Fee calculation in Section 1.1, and (ii) for all other Additional Book Eligible Recipients, used in the Base Fee calculation in Section 1.2, shall equal the sum of:
(i)
the applicable initial Additional Book Cost to Collect Factor, and
(ii)
the aggregated value of all AB Adjustments (as defined in Section 3.4) for the applicable Additional Book Eligible Recipient, as approved by the Cost Board in connection with the applicable AB Re-Assessment.”

f.
A new Section 4.3 to Exhibit 4-A is hereby added as follows:

4.3 The foregoing Base Fee reductions will be accounted for in the Parties’ calculation of the Blended Ascension Cost to Collect Factor prior to each Ascension Health Fiscal Year in which such Base Fee reduction will apply. Each such Base Fee reduction will apply only to the portion of the Steady State Base Fee attributable to the Eligible Recipient that will receive the applicable reduction and will be weighted to account for the effective date of such reduction during the upcoming Ascension Health Fiscal Year. The reductions will be applied based on the result, for such Steady State Eligible Recipient, of:
(x) the product of
(1) the Current Book Cost to Collect Factor, the Additional Book Cost to Collect Factor, or the Ascension Wisconsin Cost to Collect Factor, as applicable for such Steady State Eligible Recipient,
multiplied by

4
[**] Indicates that text has been omitted which is the subject of a confidential treatment request. The text has been separately filed with the Securities and Exchange Commission.

(2) Cash Collections received by such Steady State Eligible Recipient during the most recently completed Ascension Health Fiscal Year,
divided by
(y) the Composite Base Fee.
g.
The following is hereby added as Section 6 (Blended Base Fee) of Exhibit 4-A:

“6.1 In accordance with the provisions set forth above, for Ascension Health Fiscal Year 2019, the Blended Ascension Cost to Collect Factor shall equal [**].
6.2
Timing of Calculations. The Blended Ascension Cost to Collect Factor for each Ascension Health Fiscal Year will be calculated no later than January 31 of the immediately preceding Ascension Health Fiscal Year and will be fixed for the entirety of the upcoming Ascension Health Fiscal Year; provided that the Parties will re-calculate the Blended Ascension Cost to Collect Factor after it is fixed on a particular January 31 in the event that: (1) the Parties amend the Current Book Cost to Collect Factor, the Additional Book Cost to Collect Factor, the Ascension Wisconsin Cost to Collect Factor, the HIM Cash Collection Factor or the NRIT Cash Collection Factor, as applicable or (2) Ascension Health divests or sells a Steady State Eligible Recipient during such Ascension Health Fiscal Year. For clarity, the allocation of expenses that apply under the Supplement applicable to each Steady State Eligible Recipient or any other agreement between the Parties [**] will continue to apply pursuant to the terms of the particular Supplement or agreement, but will be aggregated for each Steady State Base Fee invoice provided in accordance with Exhibit 4-D.

II.
Base Fee Invoice. Effective as of July 1, 2018, Exhibit 4-D is hereby amended as follows:

The second sentence of Section 1(a) of Exhibit 4-D is hereby deleted in its entirety and replaced with the following sentence:

“Supplier shall provide Ascension Health with an invoice for the Base Fee fifteen (15) days before the first day of each quarter in which the Services are to be provided.”

III.
Calculation of Service Level Credits. Effective as of July 1, 2018, Exhibit 3 is hereby amended as follows:

Sections 7.3 and 7.4 of Exhibit 3 are hereby deleted in their entirety and replaced with the following:
7.3
“If Supplier’s performance for a Service Level does not achieve the Target Level in a Measurement Window, resulting in a Service Level Default for such Service Level, then Supplier shall apply a Service Level Credit for the applicable Eligible Recipient equal to the product of:

(i)
The quotient of:

a.
[**] percent ([**]%),

5
[**] Indicates that text has been omitted which is the subject of a confidential treatment request. The text has been separately filed with the Securities and Exchange Commission.



divided by

b.
the number of Service Levels with respect to such Eligible Recipient that have commenced their respective Service Level Effective Date and for which this Exhibit contains both a metric (in Article 3) and a target (in Article 4),

multiplied by
(ii)
(A) with respect to Steady State Eligible Recipients, the portion of the Steady State Base Fee attributable to such Eligible Recipient based on

(x) the product of:
(1) the Current Book Cost to Collect Factor, the Additional Book Cost to Collect Factor, or the Ascension Wisconsin Cost to Collect Factor, as applicable for such Steady State Eligible Recipient,
multiplied by
(2) Cash Collections received by such Steady State Eligible Recipient during the most recently completed Ascension Health Fiscal Year,
divided by
(y) the Composite Base Fee.
or
(B) with respect to any other Eligible Recipient, the Base Fee with respect to such Eligible Recipient for such Measurement Window,
in each case, which Service Level Credit shall be applied on the first day of the second month following the applicable Measurement Window (e.g., May 1 for a Service Level Default for the first quarter Measurement Window) for such Service Level Default.

7.4
If more than one Service Level has experienced a Service Level Default for a Measurement Window with respect to an Eligible Recipient, Supplier will apply the sum of the Service Level Credit amounts for each of the Service Levels with respect to such Eligible Recipient that had Service Level Defaults during such Measurement Window in the same manner as described in Section 7.3 above. There shall be, with respect to each Eligible Recipient, up to [**] percent ([**]%) of the portion of the Base Fee attributable to such Eligible Recipient (calculated as set forth in Section 7.3) at risk with respect to such Measurement Window (and Supplier shall in no event be liable for Service Level Credits in excess of such at risk amount).”


6
[**] Indicates that text has been omitted which is the subject of a confidential treatment request. The text has been separately filed with the Securities and Exchange Commission.

IV.
Counterparts. This Amendment may be executed in several counterparts, all of which taken together will constitute one single agreement between the Parties.

[signature page follows]

7
[**] Indicates that text has been omitted which is the subject of a confidential treatment request. The text has been separately filed with the Securities and Exchange Commission.



IN WITNESS WHEREOF, the Parties have executed and delivered this Amendment effective as of the Amendment Effective Date, first indicated above.

Ascension Health
R1 RCM Inc.

By: /s/ Rhonda C. Anderson 
Name: Rhonda C. Anderson

Title: SVP & CFO Ascension Healthcare



By: /s/ John Sparby  
Name: John Sparby 
Title: EVP Customer Operations, R1 RCM


[Signature Page to Amendment No. 3]
[**] Indicates that text has been omitted which is the subject of a confidential treatment request. The text has been separately filed with the Securities and Exchange Commission.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
6/30/1910-Q
Filed on:11/7/188-K
For Period end:9/30/18
7/1/18
2/16/163,  8-K,  SC 13D,  SC 13G/A
 List all Filings 

5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/24  R1 RCM Inc./DE                    10-K       12/31/23  130:12M                                    Workiva Inc Wde… FA01/FA
12/04/23  R1 RCM Inc./DE                    10-K/A     12/31/22  142:34M                                    Workiva Inc Wde… FA01/FA
 2/16/23  R1 RCM Inc./DE                    10-K       12/31/22  125:13M                                    Workiva Inc Wde… FA01/FA
 2/17/22  R1 RCM Holdco Inc.                10-K       12/31/21  124:12M                                    Workiva Inc Wde… FA01/FA
 2/18/21  R1 RCM Holdco Inc.                10-K       12/31/20  139:13M                                    Workiva Inc Wde… FA01/FA
↑Top
Filing Submission 0001628280-18-013834   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., May 12, 2:04:54.1pm ET